Target intelligence / Profile preview

ATP synthase subunit c (Mycobacterium tuberculosis) (AtpE)

Target
AtpE
Molecular classification
Enzyme, Membrane protein, ATP synthase subunit
01

Overview

The Mycobacterium tuberculosis F-ATP synthase c-subunit, encoded by the atpE gene, is a critical component of the F0 domain of the F1F0-ATP synthase complex. This subunit forms a membrane-embedded oligomeric ring, known as the c-ring, which acts as a rotary motor driven by the proton motive force across the bacterial inner membrane. As protons move through the interface between the c-ring and subunit a, the resulting rotation is coupled to the F1 domain to catalyze the synthesis of ATP from ADP and inorganic phosphate. This energy production is essential for the survival of M. tuberculosis in both its actively replicating and dormant, non-replicating states. In the context of disease, this target is the primary site of action for bedaquiline, a diarylquinoline antibiotic used to treat multidrug-resistant tuberculosis. Bedaquiline binds specifically to the c-subunit, physically stalling the rotation of the c-ring and thereby halting ATP production. This leads to a rapid depletion of cellular energy and subsequent bacterial death. While highly effective, mutations in the atpE gene can lead to drug resistance, and concerns regarding off-target effects on human mitochondrial ATP synthase have been noted, potentially contributing to clinical safety issues such as QT prolongation.

Other names
AtpEATP synthase C chainF-ATP synthase c-subunitc-ringF0 subunit cF-type H+-transporting ATPase subunit c
02

Mechanism of action

Inhibition of ATP synthesis by binding to the c-ring rotor, which prevents proton translocation and enzyme rotation, leading to ATP depletion and bacterial death.

03

Biological functions

ATP synthesisProton transportOxidative phosphorylationEnergy metabolismMaintenance of proton motive force
04

Disease associations

InfectionTuberculosisMultidrug-resistant tuberculosis (MDR-TB)
05

Safety considerations

QT interval prolongationOff-target inhibition of human mitochondrial ATP synthaseIncreased mortality risk in clinical trialsEmergence of drug resistance via atpE mutations
06

Interacting drugs

Bedaquiline

3 more in the full profile.

07

Biomarkers

atpE gene mutations (e.g., D32V, A63P)Intracellular ATP levels

Beyond the preview

Go deeper on ATP synthase subunit c (Mycobacterium tuberculosis) (AtpE).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ATP synthase subunit c (Mycobacterium tuberculosis) (AtpE).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call